BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy-Reference-Cited by-同舟云学术

BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy

Published:2022-08 Issue: Volume:182 Page:106323
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Porcelli Letizia,Di Fonte Roberta,Pierri Ciro L.,Fucci Livia,Saponaro Concetta,Armenio Andrea,Serratì Simona,Strippoli Sabino,Fasano Rossella,Volpicella Mariateresa,Daprile Rossana,Tommasi Stefania,Ressa Cosmo M.,Guida Michele,Azzariti Amalia

Funder

Ministero della Salute

Regione Puglia

Publisher

Elsevier BV

Subject

Pharmacology

Reference35 articles.

1. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: Molecular diversity and associated phenotypic spectrum;Sarkozy;Hum. Mutat.,2009

2. Does BRAF V600e mutation predict aggressive features in papillary thyroid cancer? results from four endocrine surgery centers;Li;J. Clin. Endocrinol. Metab.,2013

3. Targeted therapy in advanced melanoma with rare BRAF mutations;Menzer;J. Clin. Oncol.,2019

4. Acetylation-dependent regulation of BRAF oncogenic function;Dai;Cell Rep.,2022

5. Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma;Bowyer;Melanoma Res,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research;Advanced Drug Delivery Reviews;2024-05

2. Microfluidic development and biological evaluation of targeted therapy-loaded biomimetic nano system to improve the metastatic melanoma treatment;International Journal of Pharmaceutics;2024-01

3. Tumor Organoids: The Era of Personalized Medicine;Biochemistry (Moscow);2024-01

4. Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma;Journal of Experimental & Clinical Cancer Research;2023-09-28

5. A BRAF mutation-associated gene risk model for predicting the prognosis of melanoma;Heliyon;2023-05